ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy in Heterogenous Patient-Derived Xenograft Models of Triple-Negative Breast Cancer to be presented at AACR
Accesswire
*TORONTO, ON / ACCESSWIRE / March 25, 2024 / *ProteinQure, the leading startup in the computational design of peptide drugs,..